Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P608: IV iron treatment of iron deficiency anaemia with ferumoxytol in patients with inflammatory bowel disease unable to take oral iron: A randomised controlled trial vs. ferric carboxymaltoseECCO '18 Vienna
Year: 2018
Authors:

W. Strauss*, N. Dahl, J. Jiang, K. Bernard, R. Kaper, J. Krop

AMAG Pharmaceuticals, Inc., Waltham, USA

P609: Uncertain usefulness of infliximab trough levels for therapeutic decision-making in inflammatory bowel disease patients on infliximab maintenance therapyECCO '18 Vienna
Year: 2018
Authors:

F. Cañete1,2*, T. Lobatón2, E. Cabré2,3, M. Mañosa2,3, A. Teniente4, A. Clos2, P. Torres2, G. Valldosera2, E. Martínez-Cáceres4, E. Domènech2,3

1Hospital Universitari Germans Trias i Pujol, Gastroenterology, Badalona, Barcelona, Spain, 2Hospital Universitari Germans Trias i Pujol, Department of Gastroenterology, Badalona, Barcelona, Spain, 3CIBEREHD, Madrid, Spain, 4Hospital Universitari Germans Trias i Pujol, Department of Immunology, Badalona, Barcelona, Spain

P610: Risk of active Hepatitis B and C infections in the Phases 2 and 3 clinical trial programmes for ustekinumabECCO '18 Vienna
Year: 2018
Authors:

R. Gish1, P. Ramachandran2, W. Xu2, S. Sloan2*

1Stanford Medical Center, Stanford, USA, 2Janssen Research and Development, LLC, Spring House, USA

P611: Outcome in ulcerative colitis after switch from subcutaneous anti-TNF to intravenous anti-TNF: A multicentre studyECCO '18 Vienna
Year: 2018
Authors:

A. Viola1*, D. Pugliese2, S. Renna3, F. Furfaro4, F. Caprioli5, R. D'Inca'6, F. Bossa7, G. Costantino1, M. Fantini8, G. Fiorino4, A. Armuzzi2, A. Orlando3, W. Fries1

1University of Messina, IBD-unit, Department of Clinical and Experimental Medicine, Messina, Italy, 2Catholic University, IBD Unit Complesso Integrato Columbus, Fondazione Policlinico Gemelli, Rome, Italy, 3University of Palermo, "Villa Sofia-Cervello" Hospital, Di.Bi.M.I.S., Division of Internal Medicine, Palermo, Italy, 4Humanitas Research Hospital, Rozzano, IBD Center, Department of Gastroenterology, Milan, Italy, 5Ospedale Maggiore Policlinico, Milan, Gastroenterology and Endoscopy Unit, Fondazione IRCCS Cà Grande, Milano, Italy, 6University of Padua, Gastroenterology Unit, Department of Surgical, Oncological, and Gastroenterological Sciences, Padova, Italy, 7IRCCS “Casa Sollievo della Sofferenza”, San Giovanni Rotondo, Division of Gastroenterology, Foggia, Italy, 8University of Rome "Tor Vergata", Department of Systems Medicine, Rome, Italy

P612: Immunosuppressive co-treatment with infliximab and adalimumab is not superior to anti-TNF monotherapy to prevent treatment failure and treatment discontinuation in ulcerative colitisECCO '18 Vienna
Year: 2018
Authors:

S. Vieujean1, E. Louis1, C. Reenaers2*

1CHU Liège, Liège, Belgium, 2CHU Liège, Gastroenterology, Liège, Belgium

P613: Predictors of treatment persistence in ulcerative colitis patients treated with golimumab: A multicentre cohort studyECCO '18 Vienna
Year: 2018
Authors:

G. Biscaglia1, E. Savarino2, A. Variola3, F. Furfaro4, C. Ferracane5, G. Rizzati6, F. Scaldaferri6, G. Mocci7, A. Buda8, A. Privitera5, A. Geccherle3, G. Fiorino9,10*

1IRCSS Casa Sollievo della Sofferenza, Gastroenterology and Digestive Endoscopy Unit, San Giovanni Rotondo, Italy, 2University of Padua, Padua, Italy, 3Sacro Cuore Don Calabria Hospital, Negrar, Italy, 4Humanitas Clinical and Research Institute, IBD Center, Department of Gastroenterology, Rozzano, Italy, 5Cannizzaro Hospital, Catania, Italy, 6Catholic University of Sacred Heart, Internal Medicine and Gastroenterology, Rome, Italy, 7Brotzu Hospital, Gastroenterology Unit, Department of Medicine, Cagliari, Italy, 8S. Maria del Prato Hospital, Gastroenterology and Digestive Endoscopy Unit, Feltre, Italy, 9Humanitas Clinical and Research Institute, Rozzano, Italy, 10Humanitas University, Biomedical Sciences, Rozzano, Italy

P614: Pregnancy outcomes in women with IBD treated with biosimilar infliximabECCO '18 Vienna
Year: 2018
Authors:

M. Kolar1*, D. Duricova1,2, M. Bortlik1,3, M. Lukas1, V. Hruba1, N. Machkova1, K. Malickova1, M. Lukas1,4

1ISCARE I.V.F. a.s., IBD Clinical and Research Centre, Prague, Czech Republic, 21st Medical Faculty, Charles University, Institute of Pharmacology, Prague, Czech Republic, 3Military Hospital, Charles University, Department of Internal Medicine, Prague, Czech Republic, 41st Medical Faculty and General Teaching Hospital, Charles University, Institute of Medical Biochemistry, Prague, Czech Republic

P615: Efficacy of vedolizumab in patients with Crohn's disease may differ depending on the disease location: The UCLH experienceECCO '18 Vienna
Year: 2018
Authors:

T. Kumagai*, M. Vinayaga-Pavan, I. Parisi, J. Barragry, R. Sundramoorthi, L. Whitley, H. Parker, R. Kettle, N. McCabrey, E. Seward, S. McCartney, S. Bloom, R. Vega, S. Mehta, F. Rahman

University College London Hospital, Department of Gastroenterology, London, UK

P616: Utility of zinc protoporphyrin/haem ratio as a marker of iron deficiency with or without anaemia in patients with inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

E. Leventi1,2, A. Aksan2,3*, J. Stein1,2, K. Farrag1,2

1DGD Clinics Sachsenhausen, Frankfurt/Main, Germany, 2Interdisciplinary Crohn Colitis Centre Rhein-Main, Frankfurt/Main, Germany, 3Hacettepe University, Faculty of Health Sciences, Ankara, Turkey

P617: Single-centre experience with biological treatment in budesonide-refractory microscopic colitis patientsECCO '18 Vienna
Year: 2018
Authors:

N. Daferera1*, S. Ignatova2, A. Münch3

1Department of Gastroenterology and Hepatology, Linköping, Sweden, 2Department of Pathology, Linköping, Sweden, 3Department of Gastroenterology and Hepatology, Linköping, Sweden

P618: Post-operative pain following laparoscopic right hemicolectomy for Crohn’s disease a comparative studyECCO '18 Vienna
Year: 2018
Authors:

K. McKevitt*, S. Galvin, J. Burke

Beaumont Hospital, Colorectal and General Surgery, Dublin, Ireland

P619: Systematic review: Psychosocial factors associated with pain in inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

L. Sweeney1*, W. Czuber-Dochan1, R. Moss-Morris2, G. Chumbley3, L. Meade4, C. Norton1

1King's College London, Faculty of Nursing and Midwifery and Palliative Care, London, UK, 2King's College London, Health Psychology Section, London, UK, 3Imperial College Healthcare NHS Trust, Pain Service, London, UK, 4King's College London, Faculty of Life Sciences and Medicine, London, UK

P620: Golimumab in ulcerative colitis: A multi-centre real-world experienceECCO '18 Vienna
Year: 2018
Authors:

A. Kumar1*, J. Slater1, J. Jones1, T. Troth2, G. Baker3, M. Love4, J. Nahal5, D. Rattehalli1

1Russells Hall Hospital, Gastroenterology, Birmingham, UK, 2Solihull Hospital, Gastroenterology, Birmingham, UK, 3New Cross Hospital, Gastroenterology, Birmingham, UK, 4Queen Elizabeth Hospital, Gastroenterology, Birmingham, UK, 5Walsall Manor Hospital, Gastroenterology, Birmingham, UK

P621: Faecal calprotectin after the induction of anti-TNF therapy predicts mucosal healing in patients with ulcerative colitis: A prospective single-centre studyECCO '18 Vienna
Year: 2018
Authors:

L. Bertani1*, N. de Bortoli1, L. Ceccarelli2, G. Mumolo2, G. Tapete1, E. Albano1, G. Laino1, G. Di Fluri2, M. Bellini2, A. Ricchiuti2, S. Marchi1, F. Costa2

1University of Pisa, New Technologies and Translational Medicine, Pisa, Italy, 2Pisa University Hospital, General Surgery and Gastroenterology, Pisa, Italy

P622: Surgery for severely active ulcerative colitis in the era of new medical treatment: The impacts of medications on surgery avoidance, and short-term and long-term surgical outcomesECCO '18 Vienna
Year: 2018
Authors:

T. Yamamoto*, T. Shimoyama, S. Umegae

Yokkaichi Hazu Medical Centre, Inflammatory Bowel Disease Centre, Yokkaichi, Japan

P623: Quality of life as predictor of biological levels decay in inflammatory bowel diseasesECCO '18 Vienna
Year: 2018
Authors:

D. Ceballos1*, M.D. Fiuza2, I. Alarcón3

1Hospital Universitario de Gran Canaria Dr. Negrin, Gastroenterology, Las Palmas, Spain, 2Hospital Universitario de Gran Canaria Dr. Negrin, Investigation Unit, Las Palmas, Spain, 3Hospital Universitario de Gran Canaria Dr. Negrin, Clinical Analisys Laboratory, Las Palmas, Spain

P624: Vedolizumab can induce clinical remission in patients with chronic antibiotic-refractory pouchitis: A retrospective single-centre experienceECCO '18 Vienna
Year: 2018
Authors:

B. Verstockt1,2*, C. Claeys1, G. Van Assche1,2, A. D'Hoore3, A. Wolthuis3, S. Vermeire1,2, M. Ferrante1,2

1University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium, 2KU Leuven, Translational Research in Gastrointestinal Disorders, Department of Chronic Diseases, Metabolism and Ageing, Leuven, Belgium, 3University Hospitals Leuven, Dpt. Abdominal Surgery, Leuven, Belgium

P625: A prospective study to assess the effectiveness of tacrolimus therapy in ulcerative colitisECCO '18 Vienna
Year: 2018
Authors:

M. Kishi*, F. Hirai, N. Takatsu, Y. Takada, Y. Yutaka, T. Takeda, K. Yao, T. Matsui, T. Ueki

Fukuoka University Chikushi Hospital, Chikushino, Japan

P626: Development of a model of 3D imaging for the pre-operative planning of TaTMEECCO '18 Vienna
Year: 2018
Authors:

K. Sahnan1*, G. Pellino2, S.O. Adegbola1, P.J. Tozer1, P. Chandrasinghe3, D. Misovikc1, R. Hompes4, A.L. Hart5, J. Warusavitarne1, P.F. Lung6

1St Mark's Hospital, Colorectal Surgery, London, UK, 2Università della Campania “Luigi Vanvitelli”, Naples, Italy, 3University of Kelaniya, Kelaniya, Sri Lanka, 4Academic Medical Center (AMC) University of Amsterdam, Amsterdam, The Netherlands, 5St Mark's Hospital, IBD/Physiology, London, UK, 6St Mark's Hospital, Gastrointestinal Imaging, London, UK

P627: Audit of the assessment, prevalence and treatment of osteoporosis in a single-centre cohort of patients with inflammatory bowel disease managed with tumour necrosis factor inhibitor treatmentECCO '18 Vienna
Year: 2018
Authors:

O. Cronin*, S. Bell

St Vincent's Hospital Melbourne, Department of Gastroenterology, Melbourne, Australia